7 results on '"Tanjing Song"'
Search Results
2. Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.
- Author
-
Fan He, Borcherds, Wade, Tanjing Song, Xi Wei, Das, Mousumi, Lihong Chen, Daughdrill, Gary W., and Jiandong Chen
- Subjects
P53 antioncogene ,CARRIER proteins ,GENETIC transcription ,PHOSPHORYLATION ,DNA-binding proteins ,NUCLEAR magnetic resonance spectroscopy ,PROLINE - Abstract
The p53 tumor suppressor is a sequence-specific DNA binding protein that activates gene transcription to regulate cell survival and proliferation. Dynamic control of p53 degradation and DNA binding in response to stress signals are critical for tumor suppression. The p53 N terminus (NT) contains two transactivation domains (TAD1 and TAD2), a proline-rich region (PRR), and multiple phosphorylation sites. Previous work revealed the p53 NT reduced DNA binding in vitro. Here, we show that TAD2 and the PRR inhibit DNA binding by directly interacting with the sequence-specific DNA binding domain (DBD). NMR spectroscopy revealed that TAD2 and the PRR interact with the DBD at or near the DNA binding surface, possibly acting as a nucleic acid mimetic to competitively block DNA binding. In vitro and in vivo DNA binding analyses showed that the NT reduced p53 DNA binding affinity but improved the ability of p53 to distinguish between specific and nonspecific sequences. MDMX inhibits p53 binding to specific target promoters but stimulates binding to nonspecific chromatin sites. The results suggest that the p53 NT regulates the affinity and specificity of DNA binding by the DBD. The p53 NT-interacting proteins and posttranslational modifications may regulate DNA binding, partly by modulating the NT-DBD interaction. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Mutant p53 sequestration of MDM2 acidic domain inhibits E3 ligase activity.
- Author
-
Leixiang Yang, Tanjing Song, Qian Cheng, Lihong Chen, and Jiandong Chen
- Subjects
MISSENSE mutation ,TUMORS ,UBIQUITINATION ,INTRAMOLECULAR forces ,DISEASE progression - Abstract
Missense p
53 mutants often accumulate in tumors and drive progression through gain-of-function. MDM2 efficiently degrades wild type p53 , but fails to degrade mutant p53 in tumor cells. Previous studies revealed that mutant p53 inhibits MDM2 auto-ubiquitination, suggesting that the interaction inhibits MDM2 E3 activity. Recent work showed that MDM2 E3 activity is stimulated by intramolecular interaction between the RING and acidic domains. Here we show that in the mutant p53 -MDM2 complex, the mutant p53 core domain binds to the MDM2 acidic domain with significantly higher avidity compared to wild type p53 . Mutant p53 -MDM2 complex is deficient in catalyzing ubiquitin release from the activated E2 conjugating enzyme. An MDM2 construct with extra copies of the acidic domain is resistant to inhibition by mutant p53 , and efficiently promotes mutant p53 ubiquitination and degradation. The results suggest that mutant p53 interferes with the intramolecular auto-activation mechanism of MDM2, contributing to reduced ubiquitination and increased accumulation in tumor cells. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
4. Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.
- Author
-
Xi Wei, Shaofang Wu, Tanjing Song, Lihong Chen, Ming Gao, Borcherds, Wade, Daughdrill, Gary W., and Jiandong Chen
- Subjects
TUMOR proteins ,P53 protein ,EMBRYOLOGY ,P53 antioncogene ,UBIQUITIN - Abstract
The MDMX oncoprotein is an important regulator of tumor suppressor p53 activity during embryonic development. Despite sequence homology to the ubiquitin E3 ligase MDM2, MDMX depletion activates p53 without significant increase in p53 level, implicating a degradation-independent mechanism. We present evidence that MDMX inhibits the sequence-specific DNA binding activity of p53. This function requires the cooperation between MDMX and CK1α, and phosphorylation of S289 on MDMX. Depletion of MDMX or CK1α increases p53 DNA binding without stabilization of p53. A proteolytic fragment release assay revealed that in the MDMX-p53 complex, the MDMX acidic domain and RING domain interact stably with the p53 DNA binding domain. These interactions are referred to as secondary interactions because they only occur after the canonical-specific binding between the MDMX and p53 N termini, but exhibit significant binding stability in the mature complex. CK1α cooperates with MDMX to inhibit p53 DNA binding by further stabilizing the MDMX acidic domain and p53 core domain interaction. These results suggest that secondary intermolecular interaction is important in p53 regulation by MDMX, which may represent a common phenomenon in complexes containing multidomain proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
5. Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction.
- Author
-
Qian Cheng, Tanjing Song, Lihong Chen, and Jiandong Chen
- Subjects
P53 antioncogene ,MOLECULAR structure of ubiquitin ,MOLECULAR structure of amino acids ,PHOSPHORYLATION ,POST-translational modification ,UBIQUITIN genetics - Abstract
The RING domain ubiquitin E3 ligase MDM2 is a key regulator of p53 degradation and a mediator of signals that stabilize p53. The current understanding of the mechanisms by which MDM2 posttranslational modifications and protein binding cause p53 stabilization remains incomplete. Here we present evidence that the MDM2 central acidic region is critical for activating RING domain E3 ligase activity. A 30-amino-acid minimal region of the acidic domain binds to the RING domain through intramolecular interactions and stimulates the catalytic function of the RING domain in promoting ubiquitin release from charged E2. The minimal activation sequence is also the binding site for the ARF tumor suppressor, which inhibits ubiquitination of p53. The acidic domain-RING domain intramolecular interaction is modulated by ATM-mediated phosphorylation near the RING domain or by binding of ARF. These results suggest that MDM2 phosphorylation and association with protein regulators share a mechanism in inhibiting the E3 ligase function and stabilizing p53 and suggest that targeting the MDM2 autoactivation mechanism may be useful for therapeutic modulation of p53 levels. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
6. Regulation of SirT1-Nucleomethylin Binding by rRNA Coordinates Ribosome Biogenesis with Nutrient Availability.
- Author
-
Leixiang Yang, Tanjing Song, Lihong Chen, Neha Kabra, Hong Zheng, John Koomen, Edward Seto, and Jiandong Chen
- Subjects
NUCLEAR proteins ,RIBOSOMAL RNA genetics ,CARRIER proteins ,GENETIC repressors ,HETEROCHROMATIN ,RIBOSOMAL DNA - Abstract
Nucleomethylin (NML), a novel nucleolar protein, is important for mediating the assembly of the energy-dependent nucleolar silencing complex (eNoSC), which also contains SirT1 and SUV39H1. eNoSC represses rRNA transcription during nutrient deprivation, thus reducing energy expenditure and improving cell survival. We found that NML is an RNA binding protein that copurifies with 5S, 5.8S, and 28S rRNA. The SirT1 and RNA binding regions on NML showed partial overlap, and the NML-SirT1 interaction was competitively inhibited by rRNA. Nutrient deprivation triggered downregulation of rRNA transcription, reduced the level of NML-associated rRNA, and stimulated NML-SirT1 binding. Assembly of eNoSC facilitated repression of prerRNA transcription. These results suggest that nascent rRNA generates a positive-feedback signal by suppressing the assembly of eNoSC and protecting active ribosomal DNA units from heterochromatin formation. This RNA-mediated mechanism enables the eNoSC to amplify the effects of upstream nutrient-responsive regulators. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
7. Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling.
- Author
-
Levy, Dan, Kuo, Alex J, Chang, Yanqi, Schaefer, Uwe, Kitson, Christopher, Cheung, Peggie, Espejo, Alexsandra, Zee, Barry M, Liu, Chih Long, Tangsombatvisit, Stephanie, Tennen, Ruth I, Kuo, Andrew Y, Tanjing, Song, Cheung, Regina, Chua, Katrin F, Utz, Paul J, Shi, Xiaobing, Prinjha, Rab K, Lee, Kevin, and Garcia, Benjamin A
- Subjects
LYSINE ,METHYLATION ,NF-kappa B ,METHYLTRANSFERASES ,TRANSCRIPTION factors ,GENE targeting ,PHOSPHORYLATION ,PROTEIN binding ,INFLAMMATION - Abstract
Signaling via the methylation of lysine residues in proteins has been linked to diverse biological and disease processes, yet the catalytic activity and substrate specificity of many human protein lysine methyltransferases (PKMTs) are unknown. We screened over 40 candidate PKMTs and identified SETD6 as a methyltransferase that monomethylated chromatin-associated transcription factor NF-κB subunit RelA at Lys310 (RelAK310me1). SETD6-mediated methylation rendered RelA inert and attenuated RelA-driven transcriptional programs, including inflammatory responses in primary immune cells. RelAK310me1 was recognized by the ankryin repeat of the histone methyltransferase GLP, which under basal conditions promoted a repressed chromatin state at RelA target genes through GLP-mediated methylation of histone H3 Lys9 (H3K9). NF-κB-activation-linked phosphorylation of RelA at Ser311 by protein kinase C-ζ (PKC-ζ) blocked the binding of GLP to RelAK310me1 and relieved repression of the target gene. Our findings establish a previously uncharacterized mechanism by which chromatin signaling regulates inflammation programs. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.